Pelvic Inflammatory Disease: Clinical Trials

10 trials for Pelvic Inflammatory Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 unknown, 2 withdrawn, 1 not yet recruiting. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 3, Unknown 3, Withdrawn 2, Not yet recruiting 1, Terminated 1

Follow Pelvic Inflammatory Disease: new trials by email Literature Review of Pelvic Inflammatory Disease trials Research Report on Pelvic Inflammatory Disease

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy
Cyclobenzaprine - Minimally Invasive Surgical Procedures, Abnormal Uterine Bleeding, Unspecified
Phase 4Not yet recruitingChristiana Care Health Services362026-07-012026-06-24
A Randomized Controlled Trial of Treatment of Bacterial Vaginosis
Metronidazole, Placebo - Bacterial Vaginoses
Phase 4TerminatedOhio State University162021-04-262023-06-15
A Clinical Study on Qianjin Capsule of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Damp-heat Stasis and Qi Deficiency Syndrome)
Qianjin Capsule of Gynaecology - Pelvic Inflammatory Diseases
Phase 4UnknownChina Academy of Chinese Medical Sciences1842019-08-022019-07-31
A Clinical Study on Kangfu Anti-inflammatory Suppository of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Evidence of Dampness and Heat Accumulation)
Kangfu Anti-inflammatory Suppository - Pelvic Inflammatory Diseases
Phase 4UnknownChina Academy of Chinese Medical Sciences2402019-07-282019-07-29
A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease
morinidazole - Pelvic Inflammatory Disease
Phase 4UnknownJiangsu Hansoh Pharmaceutical Co., Ltd.4692016-09-012018-01-05
RCT of Postoperative Infections Following Caesarean Section Infections Following Caesarean Section
Cefuroxime - Postoperative Infection
Phase 4WithdrawnOdense University Hospital2014-10-012015-04-21
Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis
Azithromycin, Cefazolin - Endometritis
Phase 4WithdrawnUniversity of Missouri, Kansas City2012-11-012015-05-05
Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials
Moxifloxacin, Ofloxacin, Metronidazole - Pelvic Inflammatory Disease
Phase 4CompletedIstanbul Bakirkoy Maternity and Children Diseases Hospital13032010-06-012013-08-28
To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment
Ofloxacin group A, Azitromycin group B, azitromycin - Pelvic Inflammatory Disease
Phase 4CompletedGuilan University of Medical Sciences1002010-01-012010-11-16
Doxycycline Prophylaxis at Vacuum Aspiration Trial
Doxycycline pre-operatively, Doxycycline post-operatively - Endometritis
Phase 4CompletedUniversity of Pittsburgh10002007-01-012008-05-16

Narrower conditions

Endometritis (5)  ·  Surgical Wound Infection (2)  ·  Adenomyosis (1)  ·  Adnexal Diseases (1)  ·  Agnosia (1)  ·  Endometriosis (1)  ·  Infections (1)  ·  Leiomyoma (1)  ·  Menorrhagia (1)  ·  Metrorrhagia (1)  ·  Pelvic Infection (1)  ·  Urinary Tract Infections (1)  ·  Vaginitis (1)  ·  Vaginosis, Bacterial (1)

Broader conditions

Female Urogenital Diseases (10)  ·  Female Urogenital Diseases and Pregnancy Complications (10)  ·  Genital Diseases (10)  ·  Genital Diseases, Female (10)  ·  Urogenital Diseases (10)  ·  Adnexal Diseases (9)  ·  Infections (7)  ·  Pelvic Infection (5)  ·  Uterine Diseases (5)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Postoperative Complications (2)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)

Interventions

Metronidazole (2)  ·  Azithromycin (1)  ·  Cefazolin (1)  ·  Cefuroxime (1)  ·  Moxifloxacin (1)  ·  Ofloxacin (1)  ·  cyclobenzaprine (1)  ·  morinidazole (1)

Sponsors

China Academy of Chinese Medical Sciences (2)  ·  Christiana Care Health Services (1)  ·  Guilan University of Medical Sciences (1)  ·  Istanbul Bakirkoy Maternity and Children Diseases Hospital (1)  ·  Jiangsu Hansoh Pharmaceutical Co., Ltd. (1)  ·  Odense University Hospital (1)  ·  Ohio State University (1)  ·  University of Missouri, Kansas City (1)  ·  University of Pittsburgh (1)

Countries

United States (3)  ·  China (1)  ·  Denmark (1)  ·  Iran (1)  ·  Turkey (Türkiye) (1)  ·  Vietnam (1)

Top investigators

Fariba Mirblook, MD (1)  ·  Jan Stener Joergensen, MD, PhD (1)  ·  Katherine Goodpasture, DO (1)  ·  Kemal Gungorduk, md (1)  ·  Loi T Tran, MD (1)  ·  Matthew F Reeves, MD (1)  ·  Pedro Morales, MD (1)  ·  Yanming Xie (1)  ·  Yanming Xie, BA (1)

Results publications

PMID 20215625, PMID 20716255, PMID 32820536

NIH funding

R01DA013131 (1)